The largest community of pharma leaders

20 Years of Changes in Survival for Cancer

Overall cancer death rates continue to decrease in both men and women for all major racial and ethnic groups. Five-year survival for all cancer sites combined has significantly improved over the past 20 years. Factors that have contributed to the continued decrease in cancer death rates include reduced tobacco use, improved early detection (eg, colorectal, breast, and cervix), and improved treatments for many cancers. However, significant variability is reported according to the particular location of cancer. This analysis provide a nice overview of the evolution in cancer survival over the past 20 years.

In this era of increasingly personalized cancer therapy, it is hoped that dramatic progress in treatment and survival will be observed for other cancer types as well.

Source: Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival. JNCI J Natl Cancer Inst (2017) 109(9): djx030

Luca Dezzani is a Novartis employee. All the views, analysis, and perspectives are fully independent and belongs to the author only. They do not represent the views or opinions of Novartis or any other company or organization. IgeaHub is a pharmaceutical blog created and curated by Luca Dezzani.  IgeaHub does not receive any funding or support from Novartis or any other pharmaceutical company. 

Recent Articles